Drug Trial Radar · NCT06283966
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
Last checked: Nov 19, 2026Latest source record: Oct 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
5,250
Planned (sponsor's estimate)
Start
Feb 21, 2024
Primary completion
Dec 3, 2027
Study completion Dec 3, 2027
Sponsor
- Lead sponsor
- AstraZenecaAstraZeneca (AZN)
- Sponsor type
- Industry
- First posted
- Feb 28, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 40 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will evaluate the effect of triple ICS/LAMA/LABA therapy with BGF MDI 320/14.4/9.6 μg on cardiopulmonary outcomes relative to LAMA/LABA therapy with GFF MDI 14.4/9.6 μg in a population with COPD and elevated cardiopulmonary risk.
Conditions
- COPD (Chronic Obstructive Pulmonary Disease)
Interventions
BGF MDI 320/14.4/9.6 μgDrug
Budesonide, glycopyrronium, and formoterol fumarate pressurized inhalation suspension
GFF MDI 14.4/9.6 μgDrug
Glycopyrronium and formoterol fumarate pressurized inhalation suspension
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to first severe cardiac or COPD eventTime frame: Up to 3 years
Locations
922 sites in 37 countries. Site status is shown where the registry gives one.
Research Site
Athens, Alabama · Terminated
Research Site
Cullman, Alabama · Recruiting
Research Site
Fairhope, Alabama · Terminated
Research Site
Huntsville, Alabama · Terminated
Research Site
Mobile, Alabama · Recruiting
Research Site
Sheffield, Alabama · Withdrawn
Research Site
Gilbert, Arizona · Recruiting
Research Site
Glendale, Arizona · Withdrawn
Research Site
Mesa, Arizona · Recruiting
Research Site
Mesa, Arizona · Recruiting
Research Site
Phoenix, Arizona · Terminated
Research Site
Tempe, Arizona · Suspended
Research Site
Tempe, Arizona · Terminated
Research Site
Tucson, Arizona · Recruiting
Research Site
Tucson, Arizona · Recruiting
Research Site
Apple Valley, California · Withdrawn
Research Site
Canoga Park, California · Suspended
Research Site
Castroville, California · Recruiting
Research Site
Garden Grove, California · Recruiting
Research Site
Gardena, California · Terminated
Research Site
Inglewood, California · Recruiting
Research Site
La Mesa, California · Recruiting
Research Site
La Palma, California · Recruiting
Research Site
Lomita, California · Recruiting
Research Site
Long Beach, California · Recruiting
Research Site
Los Alamitos, California · Terminated
Research Site
Mission Viejo, California · Recruiting
Research Site
Newport Beach, California · Recruiting
Research Site
North Hollywood, California · Terminated
Research Site
Pomona, California · Recruiting
Research Site
Sacramento, California · Recruiting
Research Site
Sacramento, California · Recruiting
Research Site
San Bernardino, California · Terminated
Research Site
San Diego, California · Terminated
Research Site
San Dimas, California · Withdrawn
Research Site
Santa Ana, California · Withdrawn
Research Site
Tarzana, California · Recruiting
Research Site
Thousand Oaks, California · Recruiting
Research Site
Van Nuys, California · Withdrawn
Research Site
Vista, California · Recruiting
Showing 40 of 922 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.